ONL THERAPEUTICS
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly growing. Existing therapies have significant limitations and none address the initial neural component of vision loss - the death of the photoreceptor cell.
ONL THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.onltherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
734-926-5530
Email Addresses:
[email protected]
Total Funding:
57.94 M USD
Technology used in webpage:
SPF Pound Sterling Japanese Yen Oracle Cloud Campaign Monitor Widget
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bios Partners
Bios Partners investment in Series B - ONL Therapeutics
PSQ Capital
PSQ Capital investment in Series B - ONL Therapeutics
InFocus Capital Partners
InFocus Capital Partners investment in Series B - ONL Therapeutics
MINTS
MINTS investment in Series B - ONL Therapeutics
Grand Angels
Grand Angels investment in Series B - ONL Therapeutics
Kaitai Capital
Kaitai Capital investment in Series B - ONL Therapeutics
Biosciences Research and Commercialization Center (BRCC)
Biosciences Research and Commercialization Center (BRCC) investment in Series B - ONL Therapeutics
Capital Community Angel Investors
Capital Community Angel Investors investment in Series B - ONL Therapeutics
ExSight Ventures
ExSight Ventures investment in Series B - ONL Therapeutics
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series B - ONL Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-09 | ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer |
Official Site Inspections
http://www.onltherapeutics.com
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
